Reinhart Partners Loads Up on $20 Million Worth of AdaptHealth Shares

1 week ago 12

Andy Gould, The Motley Fool

Tue, April 14, 2026 astatine 11:04 AM CDT 4 min read

According to a filing with the Securities and Exchange Commission dated April 13, 2026, Reinhart Partners accrued its involvement successful AdaptHealth (NASDAQ:AHCO) by 1,981,198 shares during the archetypal quarter. The estimated transaction worth was $20.2 million, calculated from the mean closing terms implicit the period. The fund’s quarter-end presumption worth successful AdaptHealth roseate by $39.3 million, a fig that includes some banal accumulation and terms changes.

After the purchase, AdaptHealth represents astir 3.5% of Reinhart Partners' 13F reportable assets.
Top holdings aft the filing:
- NASDAQ: ACLS: $154.30 cardinal (4.4% of AUM)
- UNK: FCNCA: $147.60 cardinal (4.2% of AUM)
- NASDAQ: SIMO: $147.56 cardinal (4.2% of AUM)
- NYSE: MOD: $130.29 cardinal (3.7% of AUM)
- NASDAQ: IDCC: $127.54 cardinal (3.7% of AUM)
As of April 14, 2026, AdaptHealth shares were trading astatine $12.65, up 54% implicit the past twelvemonth and outperforming the S&P 500 by astir 26 percent points.

Metric

Value

Price (as of April 14, 2026)	$12.65
Market capitalization	$1.7 billion
Revenue (TTM)	$3.2 billion
Net income (TTM)	($70.8 million)

AdaptHealth provides location aesculapian instrumentality and supplies -- including slumber therapy devices, diabetes absorption tools, oxygen therapy, and a wide scope of chronic attraction products.
The institution operates a recurring-revenue model, supplying aesculapian instrumentality and consumables to patients and billing chiefly done Medicare, Medicaid, and commercialized security payors.
Its customers are individuals with chronic wellness conditions, peculiarly those requiring ongoing respiratory, diabetes, and mobility support, crossed the United States.

Reinhart Partners' determination to adhd astir 2 cardinal shares of AdaptHealth -- astir $20 cardinal worthy -- is simply a meaningful incremental acquisition from a money that has been gathering condemnation successful this name. This wasn't a caller position: Reinhart already held much than 8 cardinal shares heading into Q1, truthful this latest bargain represents a astir 24% summation to an already sizable stake.

AdaptHealth operates successful a abstraction that has existent structural tailwinds. An aging U.S. colonisation means increasing request for home-based attraction solutions -- precisely the benignant of recurring, insurance-reimbursed gross watercourse that semipermanent organization investors thin to find attractive. The company's premix of slumber therapy equipment, oxygen therapy, and diabetes absorption tools keeps it plugged into immoderate of the astir communal chronic conditions Americans face.

Read Entire Article